FDA to Hold Public Meeting on New Animal Drug Clinical Investigations

Summary

The FDA is hosting a public meeting to discuss incorporating alternative approaches in clinical investigations for new animal drugs, seeking input from stakeholders on guidance development to support the use of novel investigation designs, real-world evidence, and biomarkers in animal drug development.